Aging is a complex, multifactorial process that remains poorly understood at the organ-specific level. Despite advances in understanding systemic aging, the absence of reliable biomarkers or mechanistic models that explain how individual organs age limits progress in diagnostics, predictive analytics, and targeted therapies. The variability of aging processes across tissues further complicates the development of standardized markers, leaving clinicians and researchers without tools to accurately measure functional decline or predict age-related diseases.
Reason to solve: Reliable biomarkers and mechanistic models for organ aging are critical for developing precision medicine approaches to mitigate age-related functional decline. Such tools would enable earlier diagnosis of degenerative diseases, personalized treatment plans, and interventions to preserve organ function over time, ultimately improving healthspan and quality of life.
Aging is a complex, multifactorial process that remains poorly understood at the organ-specific level. Despite advances in understanding systemic aging, the absence of reliable biomarkers or mechanistic models that explain how individual organs age limits progress in diagnostics, predictive analytics, and targeted therapies. The variability of aging processes across tissues further complicates the development of standardized markers, leaving clinicians and researchers without tools to accurately measure functional decline or predict age-related diseases.
Reason to solve: Reliable biomarkers and mechanistic models for organ aging are critical for developing precision medicine approaches to mitigate age-related functional decline. Such tools would enable earlier diagnosis of degenerative diseases, personalized treatment plans, and interventions to preserve organ function over time, ultimately improving healthspan and quality of life.